GlassScriptPhysician profile
Paul J Jagielo
NPI 1457338626
$2,313.27
in general payments reported to CMS, 2019-2025
19 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $152 · 2022: $26.71 · 2023: $357 · 2024: $404 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $663.68 | 2019-2025 | Trelegy Ellipta, Nucala |
| Jazz Pharmaceuticals INC. | $357.77 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.88 | 2019-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $161.16 | 2019-2020 | |
| Genentech USA, INC. | $152.60 | 2019-2020 | |
| Mylan Specialty L.P. | $152.41 | 2023-2024 | Yupelri |
| Insmed, INC. | $139.40 | 2019-2025 | Brinsupri, Arikayce |
| Teva Pharmaceuticals USA, INC. | $96.43 | 2019 | |
| Grifols USA, LLC | $79.80 | 2019-2024 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $59.15 | 2025 | Inspire |
| Ceribell, INC. | $49.14 | 2024 | Pocket Eeg Device |
| Philips North America LLC | $45.89 | 2019-2025 | Patient Interface Software |
| Axsome Therapeutics, INC. | $33.87 | 2025 | Sunosi |
| Sunovion Pharmaceuticals INC. | $32.23 | 2019 | |
| Merck Sharp & Dohme LLC | $27.25 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $22.12 | 2023 | Flexitouch Plus, Entre Plus |
| Resmed Corp | $21.44 | 2019 | |
| Viatris Specialty LLC | $16.46 | 2025 | Yupelri |
| Shire North American Group INC | $15.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Jagielo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.